What is Chardan Capital’s Forecast for RCKT FY2025 Earnings?
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Equities research analysts at Chardan Capital upped their FY2025 earnings per share estimates for Rocket Pharmaceuticals in a research report issued to clients and investors on Sunday, March 2nd. Chardan Capital analyst Y. Livshits now expects that the biotechnology company will post earnings of ($1.25) per share […]
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Equities research analysts at Chardan Capital upped their FY2025 earnings per share estimates for Rocket Pharmaceuticals in a research report issued to clients and investors on Sunday, March 2nd. Chardan Capital analyst Y. Livshits now expects that the biotechnology company will post earnings of ($1.25) per share […]
